Share

Print

Meeting Reports and Materials

• Jan 26, 2012 Global Webinar: The Impact of Treatment as Prevention -- Models to Guide Ending the Epidemic
  This webinar featured a presentation by Dr. John Blandford and discussion of the impact of expanded antiretroviral treatment on the AIDS epidemic in specific settings.    more...   
• Nov 28, 2011 Global Advocates' Teleconference: VOICE trial update
  A call to discuss the VOICE trial DSMB recommending that the 1% tenofovir gel arm of the study be stopped and that the women in that arm exit the trial in a structured process.    more...   
• Oct 20, 2011 Global Teleconference on Hormonal Contraceptives and HIV
  A global advocates’ teleconference took place to provide an opportunity for advocates, researchers and policy makers to discuss and ask questions about recently published data on the relationship between hormonal contraceptive use and risk of HIV infection.    more...   
• Sep 30, 2011 Global Teleconference: VOICE Trial Update
  The VOICE trial team announced that the oral tenofovir pill arm of this five-arm study will close. To discuss these results with trial investigators and other key resource people, advocates were invited to join this global teleconference.    more...   
• Jul 17, 2011 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention
  The IAS Conference on HIV Pathogenesis, Treatment and Prevention has a program that includes many sessions on a range of HIV-related topics. AVAC has compiled a roadmap that includes the range of HIV prevention research-related sessions planned for the conference.    more...   
• Jul 14, 2011 Global Call to Discuss New Data from Partners PrEP and TDF2 PrEP Trials
  Researchers from two different studies of oral pre-exposure prophylaxis (PrEP) announced evidence that both oral tenofovir (TDF, marketed as Viread) and oral tenofovir plus emtricitabine (TDF/FTC, marketed as Truvada) can reduce the risk of HIV transmission among men and women whose primary...    more...   
• Jun 2, 2011 Webinar: Leveraging advocacy opportunities for Cervical Cancer at the UN High Level Meeting on NCDs
  This Webinar Panel will discuss what is needed to strengthen advocacy efforts for cervical cancer, in relation to the UN High Level Meeting (HLM) in September 2011. It offers a follow-up to a series of regional and global planning meetings on cervical cancer that have taken place over the last year.    more...   
• May 13, 2011 Global Call for Advocates to Discuss Recent Developments in HPTN 052
  Download a recording of the phone call (mp3). Summary notes are also available . HPTN 052 is a large, multi-site, randomized trial designed to determine the effectiveness of two treatment strategies in preventing the sexual transmission of HIV in couples where one partner is...    more...   
• May 5, 2011 Multipurpose Prevention Technologies for Reproductive Health
  On May 5, 2011, the US Agency for International Development (USAID), Coalition Advancing Multipurpose Innovations (CAMI), and Global Advocacy for HIV Prevention (AVAC) convened a small group of scientists with expertise in contraception, HIV and STI prevention, vaccines, and devices to discuss and recommend practical strategies for accelerating the development of multipurpose prevention technologies (MPTs) for simultaneous protection against unintended pregnancy, HIV, and other sexually-transmitted infections (STIs).    more...   
• Apr 25, 2011 ARV-Prevention Webinar: Pill versus gel and rectal microbicide update
  Please join IRMA and AVAC for a webinar that will provide an up-close look at important new microbicide data of relevance for prevention advocates. Peter Anton of UCLA and Craig Hendrix of Johns Hopkins University will review the findings they presented at the recent 18th Conference on Retroviruses and Opportunistic Infections in Boston.    more...   
• Apr 19, 2011 Global Call to Discuss Discontinuation of FEM-PrEP Trial and Steps Forward
  This global teleconference is to discuss the announcement that FEM-PrEP, an effectiveness trial of oral pre-exposure prophylaxis (PrEP) in women, not continue.    more...   
• Apr 4, 2011 IRMA Lube Safety Working Group Update
  One-hour IRMA Lube Safety Working Group Call    more...   
• Feb 27, 2011 18th Conference on Retroviruses and Opportunistic Infections
  The 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011) is a scientifically focused meeting of the world's leading researchers working to understand, prevent, and treat HIV/AIDS and its complications.    more...   
• Feb 8, 2011 Translating PrEP Research into Practice
  The global teleconference, "Translating PrEP Research into Practice," featured debate and discussion with brief remarks from key discussants on what needs to happen next to translate the iPrEx trial results outside of clinical trial settings.    more...   
• Jan 24, 2011 Lubricant Safety Update: Current Research and Advocacy Efforts
  This call covered the latest developments in lubricant safety research and advocacy. Speakers included Charlene Dezzutti of the Microbicide Trials Network, Pamina Gorbach of UCLA, and Marc-André LeBlanc, IRMA Secretary and resident lube advocacy expert (Jim Pickett filled in).    more...   
• Nov 30, 2010 Women and Microbicides: What comes after the CAPRISA Trial?
  This event described the implications of and next steps following the CAPRISA 004 microbicide trial. Particular attention was given to women’s vulnerability to HIV and the challenges of ensuring access to effective prevention products.    more...   
• Nov 24, 2010 Advocates' Briefing on iPrEx PrEP Trial Results
  This webinar served as an opportunity for advocates to hear directly from the iPrEx trial team, including a number of the iPrEx trial principal investigators from around the world who joined the call. The 90-minute session included a short presentation of the results and...    more...   
• Nov 18, 2010 "Can a pill a day prevent HIV?": Preparing for the results of the iPrEx PrEP study
  Conducted in partnership with The Desmond Tutu HIV Foundation, this webinar offered the opportunity to learn firsthand about the use of antiretrovirals for HIV prevention and explains the context, science and implications of the global iPrEx study.   Presented by members of the Cape...    more...   
• Nov 17, 2010 All Eyes on Global iPrEx: An up-close look at the PrEP effectiveness study in MSM
  This webinar provided the opportunity to learn about how the iPrEx trial was designed and conducted, including discussion of how sites in Brazil, Ecuador, Peru, South Africa, Thailand and the US engaged and collaborated with gay men and other men who have sex with men. Featured speaker:...    more...   
• Nov 17, 2010 Preparándose para los resultados de PrEP
  ¿Qué?: Preparándose para los resultados de PrEP (presentado en español) Presentación de Pedro Goicochea, investigador y comunicador sobre iPrEx y especialista en relaciones comunitarias Contenido: Este seminario, el primero de la serie de AVAC/MSMGF presentado en español,...    more...   
• Nov 3, 2010 Primes and Boosts: How might ARV-based prevention and vaccines work better together?
  This webinar will explore recent advances in ARV-based prevention research, its implications for future AIDS vaccine research and the opportunities and challenges for cooperation and integration in basic science, product development, product combinations, trial site infrastructure...    more...   
• Nov 1, 2010 Preparing for PrEP and Other ARV-based Prevention for MSM
  Conducted in partnership with the Global Forum on MSM & HIV (MSMGF), this webinar provided background on PrEP, updates on research to date and identified key issues for advocates as we prepare for the upcoming results of iPrEx, the only PrEP effectiveness study in MSM. The iPrEx study is also the first PrEP trial that will report effectiveness results.    more...   
• Oct 21, 2010 Cervical Cancer Action Webinar Series
  Cervical Cancer Action is hosting a series of global webinars to bring the latest information and experience in global cervical cancer prevention to our members and friends. These events are accessible and free of charge to everyone. Please join us!    more...   
• Oct 12, 2010 Third Annual Beth Waters Memorial Lecture
  Beth Waters, a health care public relations specialist who passed away in 2006, had a great passion for vaccine advocacy to prevent and treat diseases worldwide. In commemoration of her crusading spirit, the Global Health Council presented the third annual Beth Waters Memorial Lecture by AVAC Executive Director, Mitchell Warren.    more...   
• Oct 5, 2010 Open Forum: Give feedback on new Good Participatory Practice Guidelines
  UNAIDS and AVAC invited stakeholders in biomedical HIV prevention research to join a webinar on the draft second edition of the Good Participatory Practice (GPP) Guidelines for biomedical HIV prevention trials.    more...   
• Sep 29, 2010 The Basics of Drug Development Science – Nothing to be scared of!
  Enhance your advocacy skills and bone up on some of the basics. Jim Turpin of the Microbicide Research Branch at the National Institutes of Health, National Institutes of Allergy and Infectious Diseases, will explain the basic science of drug discovery – the research that happens before we move on to Phase I safety testing in people. Many of us find basic science confusing, daunting, and scary. Jim will show us that it doesn’t have to be any of those things, and is in fact, fascinating!    more...   
• Sep 28, 2010 AIDS Vaccine 2010
  The annual AIDS Vaccine Conference took place in Atlanta, Georgia. This year marked its tenth anniversary of collaboration, education, and the exchange of scientific ideas, all with the purpose of advancing the science of HIV vaccines. Visit the official AIDS Vaccine 2010 Conference website ....    more...   
• Jul 18, 2010 to Jul 23, 2010 XVIII International AIDS Conference (IAC)
  The International AIDS Conference is a biennial meeting of the field that brings together nearly 25,000 activists, researchers, policymakers and government officials working in HIV/AIDS and related issues. The conference covers the plethora of issues facing the field, including a track that focuses on prevention science and research.    more...   
• Jul 17, 2010 OCTAVE Workshop for Early Career Investigators on Good Participatory Practices
  The OCTAVE Project (Online Collaborative Training for AIDS Vaccine Evaluation) and the Global HIV Vaccine Enterprise, in collaboration with AVAC and UNAIDS, are organizing an interactive workshop for Young and Early Career Investigators (YECIs). This workshop will focus on the process to engage...    more...   
• Jul 12, 2010 Webinar series on Microbicides 2010 Conference
  This series of webinars based on thought-provoking presentations from the International Microbicides Conference (M2010) took place in June and July and provided advocates with a grounding in topics that were anticipated to emerge at the upcoming XVIII International AIDS Conference (IAC) in Vienna, July 18-23.    more...   
• May 22, 2010 AVAC at Microbicides 2010
  AVAC posters presented at M2010 are available to download below: Community Monitoring of the Rollout of Male Circumcision for HIV Prevention and its Implications for Women  Does PrEP need a Pipeline? Criteria for Identifying the Next PrEP Candidates Identifying Priorities, Gaps...    more...   
• May 22, 2010 to May 25, 2010 2010 International Microbicides Conference (M2010)
  The International Microbicides Conference is a biennial international gathering on microbicides. This year’s conference, with the theme of “Building Bridges in HIV Prevention”, will feature updates and sessions on microbicides and the range of HIV prevention options under currently being studied.    more...   
• May 11, 2010 Let's Take Sexy Back! Sex Can Feel Good, and Be Safe Too...
  While most safer sex and HIV prevention programmes are negative and disease-focused, The Pleasure Project is different: they take a positive, liberating and sexy approach to safer sex. Think of it as sex education ... with the emphasis on 'sex'. Join IRMA and The Pleasure Project's Anne Philpott for a global teleconference to take sexy back in our prevention work.    more...   
• Apr 20, 2010 The HIV Research Catalyst Forum: Treatment, Prevention, Advocacy
  The HIV Research Catalyst Forum: Treatment, Prevention, Advocacy (Formerly North American Treatment Action Forum—NATAF) is a conference focusing on community advocacy in HIV treatment and prevention research. From identifying research priorities to overcoming research barriers, HIV advocates...    more...   
• Mar 3, 2010 The anal canal: an important transition zone for rectal microbicide development - AVAC and IRMA
  Dr. Ross Cranston discusses the normal anal canal, anal pathology, receptive anal intercourse and anal pathology, the anal canal in the context of HIV, and the potential importance of the anal canal in the context of microbicide development.    more...   
• Feb 16, 2010 to Feb 19, 2010 17th Conference on Retroviruses and Opportunistic Infections (CROI)
  The 17th Conference on Retroviruses and Opportunistic Infections (CROI 2010) is a scientifically focused meeting of the world's leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. Visit the CROI roto website for more information on the conference program, registration and housing.    more...   
• Jan 27, 2010 Epidemiology of HIV Among MSM in Africa: Implications for rectal microbicides - AVAC and IRMA
  Listen as Chris Beyrer MD, MPH, Professor at Johns Hopkins Bloomberg School of Public Health, presents on the sobering HIV data among MSM in Africa and discuss serious challenges such as the lack of access to water-based lubricants.    more...   
• Dec 15, 2009 Advocates' briefing on results from the PRO 2000 microbicide MDP 301 study
  You are invited to join an Advocates' Tele-briefing hosted by the Global Campaign for Microbicides to discuss the key findings of MDP 301 on Tuesday 15 December 2009 at 9am DC/4pm Johannesburg. The Microbicides Development Programme (MDP) plans to announce the highly anticipated results of MDP 301 study testing the safety and effectiveness of 0.5% PRO 2000 on Monday, 14 December 2009. Leading MDP investigators will be available to share results from the study. You will have the opportunity to ask questions and discuss the potential implications of the study results.    more...   
• Dec 9, 2009 Community Perspectives on iPrEP Research: An Interactive Discussion of Issues & Opinions
  This teleconference is a continuation of the intermittent pre-exposure prophylaxis (iPrEP) conversation being organized by the Research Working Group of the PrEP Committee. Organizers hope it will provide a forum for community members to express their thoughts and opinions on iPrEP research. To learn more about iPrEP and where to get background information read our Advocates' Network posting.    more...   
• Dec 4, 2009 Efficacy and Effectiveness - What is Good Enough? Who decides?
  Join AVAC, Global Campaign for Microbicides and IRMA for a discussion about efficacy and effectiveness of new prevention technologies. The call will be held on Friday, December 4th at 10:00am US Eastern time. RSVP for Efficacy and Effectiveness - What is Good Enough? Who decides?    more...   
• Oct 22, 2009 AIDS Vaccine 2009
  This year's AIDS Vaccine Conference—an annual gathering of researchers, funders and advocates to discuss the state of the field, new research discoveries and priorities for the year ahead—was held in Paris. Click the title of this meeting to view information on this year's conference and a pre-conference satellite symposium.    more...   
• Aug 23, 2009 Preparing for PrEP: A Stakeholder's Dialogue
  The UCLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS) and various partners convened a day-long dialogue in advance of the 2009 National HIV Prevention Conference (NHPC) to discuss PrEP research, the possible social and cultural implications of PrEP and also engaged in a conversation with local PrEP trial participants. The session served to introduce attendees to PrEP and several of the related issues that were discussed in greater detail during sessions at NHPC. The webcast of the session, Preparing for PrEP: A Stakeholder's Dialogue, is available here.    more...   
• Jul 19, 2009 The Promise and Perils of ARV-Based Prevention: A Dialogue of Optimism & Informed Skepticism
  AVAC and the International AIDS Society (IAS) co-organized a satellite session on ARV-based prevention at the IAS Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town. The session, The Promise and Perils of ARV-Based Prevention: A Dialogue of Optimism & Informed Skepticism, discussed many of the implementation challenges that ARV-based prevention (PrEP among them) might face.    more...   
• Feb 19, 2009 CROI 2009 Distance Learning Series
  CHAMP and AVAC worked with partners to bring the information and dialogue from 2009 Conference on Retroviruses and Opportunistic Infections (CROI) conference to a much broader audience.    more...   
• Jan 14, 2009 AVAC Think Tank on PrEP Financing in the US
  Colleagues from multiple disciplines met for a one-day, AVAC-sponsored think tank examining how PrEP for HIV prevention might be funded or reimbursed through insurance mechanisms in the United States should it prove safe and effective. The think tank took forward discussions on PrEP implementation strategies by identifying key regulatory, legal and financial challenges to PrEP implementation.    more...   
• Dec 20, 2008 AVAC Think-Tank on Intermittent Dosing of PrEP
  In December 2008, AVAC held a one-day think tank where colleagues from multiple agencies and research disciplines discussed key scientific questions to be addressed in evaluating the merits of future prevention research on intermittent use of pre-exposure prophylaxis ("iPrEP") for prevention of HIV.    more...